SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 and correlates of protection in the UK general population

Jia Wei, Koen B. Pouwels, Nicole Stoesser, Philippa C. Matthews, Ian Diamond, Ruth Studley, Emma Rourke, Duncan Cook, John I Bell, John N Newton, Jeremy Farrar, Alison Howarth, Brian D. Marsden, Sarah Hoosdally, E Yvonne Jones, David I Stuart, Derrick W. Crook, Tim E. A. Peto, A. Sarah Walker, David W. Eyre, COVID-19 Infection Survey team
doi: https://doi.org/10.1101/2021.09.13.21263487

Article Information

doi 
https://doi.org/10.1101/2021.09.13.21263487
History 
  • January 14, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Jia Wei*,1,2,
  2. Koen B. Pouwels*,3,4,
  3. Nicole Stoesser1,3,5,6,
  4. Philippa C. Matthews1,6,
  5. Ian Diamond7,
  6. Ruth Studley7,
  7. Emma Rourke7,
  8. Duncan Cook7,
  9. John I Bell8,
  10. John N Newton9,
  11. Jeremy Farrar10,
  12. Alison Howarth1,6,
  13. Brian D. Marsden1,11,
  14. Sarah Hoosdally1,
  15. E Yvonne Jones1,
  16. David I Stuart1,
  17. Derrick W. Crook1,3,5,6,
  18. Tim E. A. Peto1,3,5,6,
  19. A. Sarah Walker#,1,2,3,12,
  20. David W. Eyre#,2,3,5,6,†,
  21. COVID-19 Infection Survey team
  1. 1Nuffield Department of Medicine, University of Oxford, Oxford, UK
  2. 2Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK
  3. 3The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK
  4. 4Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK
  5. 5The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK
  6. 6Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK
  7. 7Office for National Statistics, Newport, UK
  8. 8Office of the Regius Professor of Medicine, University of Oxford, Oxford, UK
  9. 9Health Improvement Directorate, Public Health England, London, UK
  10. 10Wellcome Trust, London, UK
  11. 11Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
  12. 12MRC Clinical Trials Unit at UCL, UCL, London, UK
  1. ↵†Corresponding author: Dr David Eyre, david.eyre{at}bdi.ox.ac.uk, +44 (0)1865 221081, Microbiology Department, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU

  1. ↵* contribution considered equal

  2. ↵# contribution considered equal

Back to top
Posted January 14, 2022.
Download PDF

Supplementary Material

Data/Code
Email
SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 and correlates of protection in the UK general population
Jia Wei, Koen B. Pouwels, Nicole Stoesser, Philippa C. Matthews, Ian Diamond, Ruth Studley, Emma Rourke, Duncan Cook, John I Bell, John N Newton, Jeremy Farrar, Alison Howarth, Brian D. Marsden, Sarah Hoosdally, E Yvonne Jones, David I Stuart, Derrick W. Crook, Tim E. A. Peto, A. Sarah Walker, David W. Eyre, COVID-19 Infection Survey team
medRxiv 2021.09.13.21263487; doi: https://doi.org/10.1101/2021.09.13.21263487
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area